MetLife Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.8M	Sell	152,645 -12,226	-7%	-$2.11M	0.13%	118
2025 Q4	$30.1M	Sell	164,871 -32,447	-16%	-$4.53M	0.15%	98
2025 Q3	$24M	Buy	197,318 +13,154	+7%	+$1.48M	0.12%	130
2025 Q2	$19.2M	Buy	184,164 +5,209	+3%	+$552K	0.11%	158
2025 Q1	$20.9M	Buy	178,955 +156,678	+703%	+$17.8M	0.11%	146
2024 Q4	$1.88M	Buy	22,277 +1,232	+6%	+$113K	0.01%	1075
2024 Q3	$1.89M	Hold	21,045	–	–	0.01%	1047
2024 Q2	$1.69M	Buy	21,045 +2,542	+14%	+$188K	0.01%	1060
2024 Q1	$1.48M	Hold	18,503	–	–	0.01%	1090
2023 Q4	$1.47M	Hold	18,503	–	–	0.01%	1103
2023 Q3	$1.29M	Buy	18,503 +1,282	+7%	+$95.8K	0.01%	1103
2023 Q2	$1.24M	Buy	17,221 +321	+2%	+$23.7K	0.01%	1146
2023 Q1	$1.04M	Hold	16,900	–	–	0.01%	1208
2022 Q4	$1.3M	Buy	16,900 +558	+3%	+$33.4K	0.01%	1083
2022 Q3	$729K	Sell	16,342 -1,006	-6%	-$50.3K	0.01%	1370
2022 Q2	$664K	Hold	17,348	–	–	0.01%	1474
2022 Q1	$718K	Buy	17,348 +6,439	+59%	+$200K	﹤0.01%	1544
2021 Q4	$412K	Hold	10,909	–	–	﹤0.01%	1610
2021 Q3	$360K	Hold	10,909	–	–	﹤0.01%	1717
2021 Q2	$736K	Hold	10,909	–	–	0.01%	1347
2021 Q1	$618K	Hold	10,909	–	–	0.01%	1400
2020 Q4	$889K	Sell	10,909 -1,403	-11%	-$105K	0.01%	1193
2020 Q3	$877K	Hold	12,312	–	–	0.01%	1092
2020 Q2	$1.01M	Buy	12,312 +680	+6%	+$52.3K	0.01%	1027
2020 Q1	$684K	Buy	11,632 +962	+9%	+$78.4K	0.01%	1059
2019 Q4	$1.1M	Sell	10,670 -1,027	-9%	-$41.5K	0.01%	1054
2019 Q3	$237K	Hold	11,697	–	–	﹤0.01%	1850
2019 Q2	$301K	Buy	+11,697	New	+$234K	﹤0.01%	1784